Anti-Obesity Drugs Among Key Medications Slated for Price Cuts in the USA
Novo Nordisk’s Ozempic and wegovy Among 15 Drugs Selected for Medicare price negotiations The biden administration has announced that Novo nordisk’s flagship drugs, Ozempic for diabetes and Wegovy for weight loss, are among the 15 medications selected for price negotiations under the Medicare program.This move, part of the Inflation Reduction Act (IRA), aims to … Read more